1
|
Weidle PJ, Brooks JT, Valentine SS, Daskalakis D. The Future of Pharmacist-Delivered Status-Neutral HIV Prevention and Care. Am J Public Health 2023; 113:256-258. [PMID: 36603170 PMCID: PMC9932376 DOI: 10.2105/ajph.2022.307190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/23/2022] [Indexed: 01/07/2023]
Affiliation(s)
- Paul J Weidle
- Paul J. Weidle, John T. Brooks, Sheila Salvant-Valentine, and Demetre Daskalakis are with the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Note. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC
| | - John T Brooks
- Paul J. Weidle, John T. Brooks, Sheila Salvant-Valentine, and Demetre Daskalakis are with the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Note. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC
| | - Sheila Salvant Valentine
- Paul J. Weidle, John T. Brooks, Sheila Salvant-Valentine, and Demetre Daskalakis are with the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Note. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC
| | - Demetre Daskalakis
- Paul J. Weidle, John T. Brooks, Sheila Salvant-Valentine, and Demetre Daskalakis are with the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Note. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC
| |
Collapse
|
2
|
Costa S, Romão M, Mendes M, Horta MR, Rodrigues AT, Carneiro AV, Martins AP, Mallarini E, Naci H, Babar ZUD. Pharmacy interventions on COVID-19 in Europe: Mapping current practices and a scoping review. Res Social Adm Pharm 2021; 18:3338-3349. [PMID: 34924315 PMCID: PMC8670105 DOI: 10.1016/j.sapharm.2021.12.003] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2021] [Revised: 12/10/2021] [Accepted: 12/11/2021] [Indexed: 02/07/2023]
Abstract
Background The COVID-19 pandemic has put community pharmacists at the frontline of prevention, preparedness, response, and recovery efforts. Pharmacies had to reorganize and implement several different interventions and measures within a very short time frame. Objectives 1) To map the current reported practice and trends and to review the literature on pharmacy-based interventions on COVID-19 provided in Europe; 2) To identify knowledge gaps and future avenues for pharmacy research, policy, and practice in response to public health emergencies. Methods We used a mixed methods approach combining country mapping of current practices of pharmacy interventions on COVID-19 reported by pharmacy associations in Europe with a scoping review of published literature. Results We mapped current practices on 31 pharmacy interventions on COVID-19 in 32 countries in Europe. Almost all preventive measures to reduce health risks have been provided in most countries. Other frequent interventions reflected preparedness for stockpiling, increased demand for services and products, and important patient care interventions exceeding dispensing role. Expanded powers granted to pharmacies and legislation passed in view of COVID-19 enabled services that improve access to medicines and relevant products, patient screening and referral including point-of-care antigen testing, support to vulnerable patients, and COVID-19 vaccination. We identified 9 studies conducted in pharmacies in 7 countries in Europe. Most studies are cross-sectional and/or descriptive. Pharmacy associations played an important supporting role by developing and updating guidance and emergency plans to assist community pharmacists. Conclusions A wide array of pharmacy interventions on COVID-19 was implemented in several countries within a very short time frame. Research on pharmacy interventions on COVID-19 is still in its infancy but confirmed the wide array of interventions provided and expanded powers granted to pharmacies. These findings may provide a significant impact to improve pharmacy research, policy, and practice in response to future public health emergencies in Europe and globally.
Collapse
Affiliation(s)
- Suzete Costa
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
| | - Mariana Romão
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; Centre for Health Evaluation & Research (CEFAR), Infosaúde, Associação Nacional das Farmácias (ANF), R. Marechal Saldanha, 1, 1249-069 Lisboa, Portugal.
| | - Maria Mendes
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; Centre for Medicines Information and Health Interventions (CEDIME), Infosaúde, Associação Nacional das Farmácias (ANF), R. Marechal Saldanha, 1, 1249-069 Lisboa, Portugal.
| | - Maria Rute Horta
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; Centre for Medicines Information and Health Interventions (CEDIME), Infosaúde, Associação Nacional das Farmácias (ANF), R. Marechal Saldanha, 1, 1249-069 Lisboa, Portugal.
| | - António Teixeira Rodrigues
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; Centre for Health Evaluation & Research (CEFAR), Infosaúde, Associação Nacional das Farmácias (ANF), R. Marechal Saldanha, 1, 1249-069 Lisboa, Portugal.
| | - António Vaz Carneiro
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; Institute for Preventive Medicine and Public Health, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
| | - Ana Paula Martins
- Institute for Evidence-Based Health (ISBE), Faculdade de Medicina da Universidade de Lisboa, Edifício Reynaldo dos Santos, Piso 3, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal; Pharmacy, Pharmacology and Health Technologies, Faculdade de Farmácia da Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal.
| | - Erika Mallarini
- SDA Bocconi School of Management, Via Sarfati, 10, 20136, Milano, Italy.
| | - Huseyin Naci
- Department of Health Policy, London School of Economics and Political Science (LSE), Houghton Street, London WC2A 2AE, UK.
| | - Zaheer-Ud-Din Babar
- Department of Pharmacy, University of Huddersfield, Queensgate, Huddersfield, West Yorkshire, HD1 3DH, UK.
| |
Collapse
|
3
|
Waszyk-Nowaczyk M, Guzenda W, Kamasa K, Pawlak K, Bałtruszewicz N, Artyszuk K, Białoszewski A, Merks P. Cooperation Between Pharmacists and Physicians - Whether It Was Before and is It Still Ongoing During the Pandemic? J Multidiscip Healthc 2021; 14:2101-2110. [PMID: 34393489 PMCID: PMC8357703 DOI: 10.2147/jmdh.s318480] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Accepted: 06/28/2021] [Indexed: 12/23/2022] Open
Abstract
Nowadays, it is very important to put an emphasis on widely understood teamwork. This is of great importance for achieving and maintaining success in all areas, especially in medicine. This kind of unity has many advantages, including unique ideas that are very helpful in a competitive environment, improve performance and knowledge, and create stronger supportive work relationships. Patient’s health can be improved by using comprehensive treatment. This provides an urgent need for multidisciplinary partnership in the medical community. Optimal pharmacological treatment is crucial to achieving treatment goals. To ensure excellent quality of medical care, interprofessional cooperation between physicians and pharmacists and/or other medical professionals is necessary. Their complementary knowledge and experience can lead to improved health outcomes and can also reduce treatment costs. There are also many barriers and difficulties in legal systems that would allow for more effective inter-professional cooperation. The COVID-19 pandemic contributed to emphasizing the role of the pharmacist, increasing powers, and at the same time to teamwork, sometimes forced by the situation. The purpose of this publication is to view the literature on the cooperation of physicians and pharmacists in the provision of medical services for patients. Professional cooperation has been well known in many countries for years, as it is a key medium supporting optimized patient care. Analyzing the challenges and approaches can lead to better and improved health care.
Collapse
Affiliation(s)
- Magdalena Waszyk-Nowaczyk
- Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, 60-780, Poland
| | - Weronika Guzenda
- Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, 60-780, Poland
| | - Karolina Kamasa
- Student's Pharmaceutical Care Group, Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, 60-780, Poland
| | - Kornel Pawlak
- Student's Pharmaceutical Care Group, Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, 60-780, Poland
| | - Natalia Bałtruszewicz
- Student's Pharmaceutical Care Group, Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, 60-780, Poland
| | - Karolina Artyszuk
- Student's Pharmaceutical Care Group, Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, Poznan, 60-780, Poland
| | - Artur Białoszewski
- Department of the Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, 02-091, Poland
| | - Piotr Merks
- Faculty of Medicine, Cardinal Stefan Wyszyński University, Warsaw, 01-938, Poland
| |
Collapse
|